Jason D Washington, PA
Physician Assistant · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Office
- 1
- Since medical school
- 18 years
- Graduated 2008
Offices
1 location · Regents Univ of California UCSF · 276 clinicians in this group
Looking this up.
Hospitals listed: Marinhealth Medical Center. That is not proof they admit you there this week.
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Jason D Washington’s office at (415) 476-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Marinhealth Medical CenterGreenbrae, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of MarinHealthPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.66 (3.59 to 7.73) · 1,505 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.177, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025
See every measure and the patient survey for Marinhealth Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 3 better, 8 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.66 (3.59 to 7.73) · 1,505 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.177 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.85 (0 to 1.83) · 1,056 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.04 (0.72 to 1.36) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.34 (112.58 to 222.09) · 57 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 47 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 119 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.6 · 257 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 428 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.4 · 477 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 197 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,827 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.38) · 6,990 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.41) · 6,838 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.41 (0 to 3) · 664 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.86 (1.4 to 4.33) · 1,436 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.38 (3.68 to 17.08) · 705 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.38 (0.72 to 8.04) · 672 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.18 to 3.15) · 300 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.56 (0 to 1.25) · 5,550 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 76 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.396 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 275 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 427 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -20.3 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 3.3 · 494 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4.9 · 499 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 435 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.6 to 8.4) · 93 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.2 (7.8 to 16) · 93 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.6 · 84 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 111 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (10.3 to 16.5) · 2,119 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.4) · 670 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,233 patients answered, 19% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 68% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 48% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
Drugs they prescribed that Part D paid
$7,900
Pharmacies billed $7,900 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 20% of their Part D prescriptions (48 of 243) in 2024. Above the middle of the specialty; the typical physician assistant clinician is at 1%.
225 generic and 18 brand-name prescriptions · $7,900 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Pantoprazole | 17 | $114 | $7 |
| Oxycodone | 31 | $108 | $3 |
| Metoprolol | 15 | $55 | $3 |
| Potassium Chloride | 21 | $53 | $3 |
| Gabapentin | 13 | $31 | $2 |
See all 7 drugs
| Pantoprazole | 17 | $114 | $7 |
| Oxycodone | 31 | $108 | $3 |
| Metoprolol | 15 | $55 | $3 |
| Potassium Chloride | 21 | $53 | $3 |
| Gabapentin | 13 | $31 | $2 |
| Tramadol | 15 | $26 | $2 |
| Furosemide | 23 | $22 | $1 |
Year by year
| 2024 | 243 | 68 | 20% (48) | 7% | $7,900 |
| 2023 | 141 | 41 | 21% (30) | None | $5,970 |
| 2022 | 11 | None | None | None | $472 |
| 2021 | 41 | 17 | None | None | $431 |
| 2020 | 176 | 44 | None | 26% | $12,638 |
| 2019 | 216 | 54 | None | 17% | $6,476 |
| 2018 | 88 | 27 | None | 20% | $2,231 |
| 2017 | 36 | 13 | None | 0% | $380 |
| 2016 | 88 | 23 | None | 20% | $1,561 |
| 2015 | 152 | 36 | None | 13% | $3,499 |
| 2014 | 193 | 35 | 8% (16) | None | $4,285 |
| 2013 | 208 | 33 | 10% (20) | 8% | $3,950 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Oxycodone | 21 | $120 | $6 |
| Potassium Chloride | 15 | $75 | $5 |
| Furosemide | 14 | $16 | $1 |
2020: 7 drugs
| Eliquis | 22 | $10,498 | $477 |
| Amiodarone | 13 | $366 | $28 |
| Metoprolol | 22 | $75 | $3 |
| Potassium Chloride | 16 | $69 | $4 |
| Atorvastatin | 12 | $53 | $4 |
| Furosemide | 18 | $35 | $2 |
| Clopidogrel | 11 | $29 | $3 |
2019: 7 drugs
| Famotidine | 32 | $225 | $7 |
| Amiodarone | 18 | $179 | $10 |
| Atorvastatin | 15 | $124 | $8 |
| Metoprolol | 28 | $117 | $4 |
| Potassium Chloride | 14 | $117 | $8 |
| Clopidogrel | 11 | $51 | $5 |
| Furosemide | 13 | $37 | $3 |
2018: 2 drugs
| Metoprolol | 13 | $43 | $3 |
| Furosemide | 12 | $27 | $2 |
2016: 1 drug
| Pantoprazole | 15 | $72 | $5 |
2015: 4 drugs
| Atorvastatin | 14 | $435 | $31 |
| Clopidogrel | 17 | $158 | $9 |
| Metoprolol | 19 | $63 | $3 |
| Famotidine | 11 | $58 | $5 |
2014: 5 drugs
| Clopidogrel | 21 | $409 | $19 |
| Atorvastatin | 23 | $276 | $12 |
| Hydrocodone-Acetaminophen | 13 | $166 | $13 |
| Metoprolol | 27 | $151 | $6 |
| Famotidine | 22 | $145 | $7 |
2013: 5 drugs
| Clopidogrel | 29 | $872 | $30 |
| Hydrocodone-Acetaminophen | 20 | $292 | $15 |
| Atorvastatin | 15 | $252 | $17 |
| Famotidine | 32 | $247 | $8 |
| Metoprolol | 25 | $163 | $7 |
Money from drug and device companies
$651 in 2025
| 2025 | 3 | 11 | None | $651 |
| 2024 | 2 | 5 | None | $238 |
| 2023 | 6 | 25 | None | $2,629 |
| 2022 | 3 | 5 | None | $267 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbott Laboratories | Epic | $549 | 7 payments
|
| AtriCure | Atricure Cryoice Cryoablation System (Cryo2) | $76 | 3 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $26 | 1 payment
|
See all 11 published payments
| Abbott Laboratories | Meals · 2025-12-02 | Epic | $11 |
| Abbott Laboratories | Meals · 2025-11-12 | Epic | $23 |
| Abbott Laboratories | Meals · 2025-11-12 | Epic | $168 |
| AtriCure | Meals · 2025-10-30 | Atriclip Laa Exclusion System | $14 |
| Abbott Laboratories | Meals · 2025-09-11 | Epic | $37 |
| Abbott Laboratories | Meals · 2025-08-22 | Epic | $24 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-04-30 | Lifevest | $26 |
| Abbott Laboratories | Meals · 2025-02-26 | Epic | $164 |
| AtriCure | Meals · 2025-02-14 | Atriclip Laa Exclusion System | $17 |
| AtriCure | Meals · 2025-02-12 | Atricure Cryoice Cryoablation System (Cryo2) | $46 |
| Abbott Laboratories | Meals · 2025-02-05 | Epic | $121 |
See earlier years (2024, 2023, 2022)
2024: $238
| Getinge USA Sales | Vasoview Hemopro 2 | $213 | 4 payments
|
| Atricure | Atricure Cryoice Cryosphere Cryoablation System | $25 | 1 payment
|
2023: $2,629
| Atricure | Synergy Ablation System | $1,408 | 12 payments
|
| Medical Device Business Services | Stratafix | $1,008 | 7 payments
|
| Getinge USA Sales | Vasoview Hemopro 2 | $91 | 2 payments
|
| Cerus | Intercept Blood System for Platelets | $65 | 1 payment
|
| Novartis Pharmaceuticals | Leqvio | $44 | 2 payments
|
| Merck Sharp & Dohme | Verquvo | $13 | 1 payment
|
2022: $267
| Baxter Healthcare | Coseal | $120 | 1 payment
|
| Getinge USA Sales | Vasoview Hemopro 2 | $120 | 3 payments
|
| AtriCure | Atricure Cryoice Cryosphere Cryoablation System | $27 | 1 payment
|
Professional record
- NPI
- 1457503526
- Licence
- CA 53124
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Physician assistant (363A00000X)
- Mailing address
- 100 Wilson Rd Ste 100, Monterey, CA, 93940
- NPI first listed
- 2008-10-21
- NPI last updated
- 2026-07-17
- NPI record certified
- 2026-07-17
This is when the NPI record was last certified, not a medical board exam.